Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection

To compare the cost, efficacy and cost efficacy of tazobactam/piperacillin and imipenem/cilastatin in the treatment of intra-abdominal infection. The analysis was retrospective and based on a decision tree. Effectiveness data were obtained from 19 published clinical trials. Direct costs were quantif...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2001-01, Vol.19 (1), p.79-94
Hauptverfasser:	Dietrich, E S, Schubert, B, Ebner, W, Daschner, F
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen - microbiology Adult Antibacterials Bacterial Infections - drug therapy Bacterial Infections - economics cilastatin Cilastatin - economics Cilastatin - therapeutic use Cost analysis Cost-Benefit Analysis Decision Trees Drug Combinations Drug Costs Drug Therapy, Combination - economics Drug Therapy, Combination - therapeutic use Health Care Costs Health technology assessment Humans Imipenem Imipenem - economics Imipenem - therapeutic use Intra abdominal infections Penicillanic Acid - analogs & derivatives Penicillanic Acid - economics Penicillanic Acid - therapeutic use Pharmacoeconomics piperacillin Piperacillin - economics Piperacillin - therapeutic use Protease Inhibitors - economics Protease Inhibitors - therapeutic use Randomized Controlled Trials as Topic Retrospective Studies Tazobactam Thienamycins - economics Thienamycins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!